ipamorelin half-life in humans pharmacokinetics Biological Peptide Therapy Promise & Pitfalls

ThinWorks provides CJC 1295 Ipamorelin Peptide Therapy in Palm Beach Gardens , Florida, to help with health and fitness goals

(JCEM 2006) They documented a 2- to 10-fold increase in plasma GH (dose-dependent), a 1.5- to 3-fold increase in IGF-1 for 9-11 days, and a half-life of 5.8 to 8.1 days

Research Context: Investigated in preclinical research models studying: Peptide selectivity Receptor binding characteristics Technical Information: Amino Acid Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH Amino Acid Length: 5 Molecular Weight: ~711 Da Form: Lyophilised powder Quantity: 5mg Storage & Handling: Store at -20C Handle using sterile laboratory technique Research Handling Note: For best results in a research setting, allow both: the peptide and chosen solvent to reach ambient laboratory temperature before reconstitution

Ipamorelin works within the body's own feedback loops, meaning natural somatostatin suppression prevents GH from rising to excessive levels

It has never completed Phase III clinical trials and remains classified as a research compound

Store refrigerated between 2C and 8C and protect from excessive heat, moisture, and direct light